| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.7M | -2.4% |
| R&D Expense | $57.5M | -6.6% |
| SG&A Expense | $18.5M | -18.1% |
| Operating Income | -$73.0M | +4.1% |
| Income Tax | $0 | — |
| Net Income | -$63.1M | +8.8% |
| EPS (Basic) | -$1.65 | +9.8% |
| EPS (Diluted) | -$1.65 | +9.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.2M | -33.3% |
| Short-term Investments | $40.1M | -56.1% |
| Current Assets | $50.8M | -51.9% |
| Total Assets | $99.6M | -37.6% |
| Current Liabilities | $15.9M | -22.5% |
| Total Liabilities | $42.4M | -9.8% |
| Stockholders' Equity | $57.2M | -49.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.3M | +11.8% |
| Capital Expenditures | $41K | -80.1% |
| Investing Cash Flow | $57.6M | -19.0% |
| Financing Cash Flow | $108K | -57.3% |
| Free Cash Flow | -$61.3M | +12.0% |